Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

Université Laval

$32,000.00

New peptidomimetic approaches to target protein-protein interactions

EF 2014-15

Résumé
The cellular functions of a vast majority of proteins are performed through physical interactions with other proteins. These protein-protein interactions (PPI) are essential for many cellular and biological processes. Therefore, the inhibition of these interactions with chemical compounds provides great potential for the discovery of novel therapeutic agents and the development of innovative molecular tools to improve our understanding of biochemical pathways. Most of these PPI happen inside the cells. As a result, the demand for molecules that are able to penetrate cells and selectively disrupt specific PPI is rapidly increasing.This research proposal describes novel approaches for the development of engineerable peptidomimetic molecular scaffolds. These molecules are able to mimic different protein secondary structures required for molecular recognition and involved in PPI. In part I, cyclic peptoids (N-substituted glycines) are developed as potential peptidomimetic scaffolds and their structural behaviours and abilities to penetrate cells are investigated. In part II, the development of a novel synthetic approach to prepare heterocyclic scaffolds with privileged structures for the discovery of PPI inhibitors is described.The development of protein-protein interaction inhibitors is a challenging and important goal in the context of fundamental research and pharmaceutical lead discovery. The ability to rationally engineer cyclic peptoids and privileged structure scaffolds with drug-like passive membrane permeability will open new possibilities to inhibit intracellular proteins. The development of these novel engineerable peptidomimetic scaffolds will have an important impact in medicinal chemistry, chemical biology, and life sciences since protein-binding molecules are potential pharmacological agents, molecular tools to study biochemical pathways, and protein capture agents for the purification or detection of proteins in complex mixtures.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
371503-2010
Name nom
Biron, Eric
Department département
Pharmacie, Faculté de
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2010
Award amount
32000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
3700
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Organic chemistry
Research subject fr
Chimie organique
Partie
5
Nb partie
5
Application title
New peptidomimetic approaches to target protein-protein interactions
Keyword
NSERC
Application summary
The cellular functions of a vast majority of proteins are performed through physical interactions with other proteins. These protein-protein interactions (PPI) are essential for many cellular and biological processes. Therefore, the inhibition of these interactions with chemical compounds provides great potential for the discovery of novel therapeutic agents and the development of innovative molecular tools to improve our understanding of biochemical pathways. Most of these PPI happen inside the cells. As a result, the demand for molecules that are able to penetrate cells and selectively disrupt specific PPI is rapidly increasing.This research proposal describes novel approaches for the development of engineerable peptidomimetic molecular scaffolds. These molecules are able to mimic different protein secondary structures required for molecular recognition and involved in PPI. In part I, cyclic peptoids (N-substituted glycines) are developed as potential peptidomimetic scaffolds and their structural behaviours and abilities to penetrate cells are investigated. In part II, the development of a novel synthetic approach to prepare heterocyclic scaffolds with privileged structures for the discovery of PPI inhibitors is described.The development of protein-protein interaction inhibitors is a challenging and important goal in the context of fundamental research and pharmaceutical lead discovery. The ability to rationally engineer cyclic peptoids and privileged structure scaffolds with drug-like passive membrane permeability will open new possibilities to inhibit intracellular proteins. The development of these novel engineerable peptidomimetic scaffolds will have an important impact in medicinal chemistry, chemical biology, and life sciences since protein-binding molecules are potential pharmacological agents, molecular tools to study biochemical pathways, and protein capture agents for the purification or detection of proteins in complex mixtures.